Your browser doesn't support javascript.
loading
A new look at cognitive functioning in pediatric MS.
Krupp, Lauren B; Waubant, Emmanuelle; Waltz, Michael; Casper, T Charles; Belman, Anita; Wheeler, Yolanda; Ness, Jayne; Graves, Jennifer; Gorman, Mark; Benson, Leslie; Mar, Soe; Goyal, Manu; Schreiner, Teri; Weinstock-Guttman, Bianca; Rodriguez, Moses; Tillema, Jan-Mendelt; Lotze, Timothy; Aaen, Greg; Rensel, Mary; Rose, John; Chitinis, Tanuja; George, Allan; Charvet, Leigh E.
Afiliación
  • Krupp LB; Multiple Sclerosis Comprehensive Care Center, Department of Neurology, NYU Langone Health, New York, NY, USA.
  • Waubant E; Pediatric Multiple Sclerosis Center, University of California San Francisco, San Francisco, CA, USA.
  • Waltz M; Data Coordinating and Analysis Center, The University of Utah, Salt Lake City, UT, USA.
  • Casper TC; Data Coordinating and Analysis Center, The University of Utah, Salt Lake City, UT, USA.
  • Belman A; Multiple Sclerosis Comprehensive Care Center, Department of Neurology, NYU Langone Health, New York, NY, USA.
  • Wheeler Y; Center for Pediatric-Onset Demyelinating Disease, The University of Alabama at Birmingham, Birmingham, AL, USA.
  • Ness J; Center for Pediatric-Onset Demyelinating Disease, The University of Alabama at Birmingham, Birmingham, AL, USA.
  • Graves J; Pediatric Multiple Sclerosis Center, University of California San Diego, San Diego, CA, USA.
  • Gorman M; Pediatric Multiple Sclerosis and Related Disorders Program at Boston Children's Hospital, Boston, MA, USA.
  • Benson L; Pediatric Multiple Sclerosis and Related Disorders Program at Boston Children's Hospital, Boston, MA, USA.
  • Mar S; Washington University in St. Louis, St. Louis, MO, USA.
  • Goyal M; Washington University in St. Louis, St. Louis, MO, USA.
  • Schreiner T; Rocky Mountain Multiple Sclerosis Center, Children's Hospital Colorado, University of Colorado Denver, Aurora, CO, USA.
  • Weinstock-Guttman B; Jacobs Pediatric Multiple Sclerosis Center, State University of New York at Buffalo, Buffalo, NY, USA.
  • Rodriguez M; Mayo Clinic Pediatric Multiple Sclerosis Center, Mayo Clinic, Rochester, MN, USA.
  • Tillema JM; Mayo Clinic Pediatric Multiple Sclerosis Center, Mayo Clinic, Rochester, MN, USA.
  • Lotze T; The Blue Bird Circle Clinic for Multiple Sclerosis, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
  • Aaen G; Pediatric Multiple Sclerosis Center, Loma Linda University Children's Hospital, Loma Linda, CA, USA.
  • Rensel M; Cleveland Clinic Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA.
  • Rose J; Data Coordinating and Analysis Center, The University of Utah, Salt Lake City, UT, USA.
  • Chitinis T; Partners Pediatric Multiple Sclerosis Center, Massachusetts General Hospital, Boston, MA, USA.
  • George A; Multiple Sclerosis Comprehensive Care Center, Department of Neurology, NYU Langone Health, New York, NY, USA.
  • Charvet LE; Multiple Sclerosis Comprehensive Care Center, Department of Neurology, NYU Langone Health, New York, NY, USA.
Mult Scler ; 29(1): 140-149, 2023 01.
Article en En | MEDLINE | ID: mdl-36189711
ABSTRACT

OBJECTIVE:

Cognitive involvement in pediatric multiple sclerosis (MS) relative to adult MS is less defined. This study advances our understanding by measuring cognitive performances in pediatric MS, adult MS, and pediatric healthy controls.

METHODS:

Consecutive relapsing pediatric MS participants from the United States Network of Pediatric MS Centers were compared with pediatric healthy controls and adults with relapsing MS. Participants were compared on two screening batteries the Brief International Cognitive Assessment for MS and the Cogstate Brief Battery. Results were transformed to age-normative z scores.

RESULTS:

The pediatric groups (MS vs. Healthy Controls) did not differ on either battery's composite mean score or individual test scores (ps > 0.32), nor in the proportions impaired on either battery, Brief International Cognitive Assessment for MS (26% vs. 24%, p = 0.83); Cogstate Brief Battery (26% vs. 32%, p = 0.41). The pediatric versus adult MS group even after controlling for differences in disease duration performed better on the Brief International Cognition Assessment for MS composite (p = 0.03), Symbol Digit Modalities Test (p = 0.02), Rey Auditory Verbal Learning Test (p = 0.01), and Cogstate choice reaction time (p < 0.001).

CONCLUSION:

Pediatric MS patients do not differ from healthy pediatric controls on cognitive screens but perform better than adults with MS.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos del Conocimiento / Disfunción Cognitiva / Esclerosis Múltiple Límite: Adult / Child / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos del Conocimiento / Disfunción Cognitiva / Esclerosis Múltiple Límite: Adult / Child / Humans Idioma: En Año: 2023 Tipo del documento: Article